Recommendations for assessing Patient‐Reported Outcomes and Health‐Related quality of life in clinical trials on allergy: a GA2LEN taskforce position paper
Open accessThe DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.
Abstract
To cite this article: Baiardini I, Bousquet PJ, Brzoza Z, Canonica GW, Compalati E, Fiocchi A, Fokkens W, van Wijk RG, La Grutta S, Lombardi C, Maurer M, Pinto AM, Ridolo E, Senna GE, Terreehorst I, Todo Bom A, Bousquet J, Zuberbier T, Braido F. Recommendations for assessing Patient‐Reported Outcomes and Health‐Related quality of life in clinical trials on allergy: a GA 2 LEN taskforce position paper. Allergy 2010; 65: 290–295. The aim of this Global Allergy and Asthma European Network (GA 2 LEN) consensus report is to provide recommendations for patient‐reported outcomes (PROs) evaluation in clinical trials for allergic diseases, which constitute a global health problem in terms of physical, psychological economic and social impact. During the last 40 years, PROs have gained large consideration and use in the scientific community, to gain a better understanding of patients’ subjective assessment with respect to elements concerning their health condition. They include all health‐related reports coming from the patient, without involvement or interpretation by physician or others. PROs assessment should be performed by validated tools (disease‐specific tools when available or generic ones) selected taking into account the aim of the study, the expected intervention effects and the determinant and confounding factors or patient‐related factors which could influence PROs. Moreover, each tool should be used exclusively in the patient population following the authors’ indications without modification and performing a cross‐cultural validation if the tool must be used in a language that differs from the original. The result analysis also suggests that the relevance of PROs results in any interventional study should include a pre–post assessment providing information concerning statistical differences within or among groups, rates of response for the PROs and a minimal important difference for the population. The report underlines the importance of further investigation on some topics, such as the quality assessment of existing PROs tools, the definition of inclusion and exclusion criteria and a more extensive evaluation of the correlation between PROs, besides health‐related quality of life, and clinical data.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Pain: a review of three commonly used pain rating scales
Williamson, A., & Hoggart, B. (2005) · Journal of Clinical Nursing · doi:10.1111/j.1365-2702.2005.01121.x · Cited by 3,083
Development of the asthma control test
Nathan, R. A., Sorkness, C. A., Kosinski, M., Schatz, M., Li, J. T., Marcus, P., Murray, J. J., & Pendergraft, T. B. (2004) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2003.09.008 · Cited by 2,906
A critical review of visual analogue scales in the measurement of clinical phenomena
Wewers, M. E., & Lowe, N. K. (1990) · Research in Nursing & Health · doi:10.1002/nur.4770130405 · Cited by 2,580 · cited 2×
“l The VAS is a technique used to measure subjective phenomena (34).”
BackgroundMethodSackett, D. L. (1979) · Journal of Chronic Diseases · doi:10.1016/0021-9681(79)90012-2 · Cited by 2,075
Quality of Life: The Assessment, Analysis and Interpretation of Patient‐Reported Outcomes
Fayers, P. M., & Machin, D. (2007) · doi:10.1002/9780470024522 · Cited by 865
Patient-Reported Outcomes to Support Medical Product Labeling Claims: FDA Perspective
Patrick, D. L., Burke, L. B., Powers, J. H., Scott, J. A., Rock, E. P., Dawisha, S., O'Neill, R., & Kennedy, D. L. (2007) · Value in Health · doi:10.1111/j.1524-4733.2007.00275.x · Cited by 726 · cited 1×
“PROs include all health-related reports coming from the patient, without involvement or interpretation by physician or others, such as symptoms, HRQL, illness perception, satisfaction or adherence to treatment (3).”
BackgroundThe visual analogue scale: Its use in pain measurement
Langley, G. B., & Sheppeard, H. (1985) · Rheumatology International · doi:10.1007/bf00541514 · Cited by 619 · cited 1×
“It is considered a robust, sensitive and reproducible method for symptom assessment (35).”
MethodLEWIS-JONES, S. (2006) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2006.01047.x · Cited by 478 · cited 1×
“Health-related quality of life impairment has been well established for rhinitis, asthma (13), atopic dermatitis (14), urticaria (15) and food (16).”
BackgroundQuality of Life in Allergic Rhinitis and Asthma
LEYNAERT, B., NEUKIRCH, C., LIARD, R., BOUSQUET, J., & NEUKIRCH, F. (2000) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.162.4.9912033 · Cited by 407 · cited 2×
“rhinitis vs asthma patients (13)] or between patients and healthy subjects (31).”
BackgroundSelf-citationBachert, C., Bousquet, J., Canonica, G. W., Durham, S. R., Klimek, L., Mullol, J., Van Cauwenberge, P. B., & Van Hammée, G. (2004) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2004.05.070 · Cited by 215 · cited 1×
“The development of clinical trials in which PROs are the primary or co-primary (29) outcome is recommended because appropriate tools are available.”
MethodSelf-citation
Cited by
Maurer, M., Weller, K., Bindslev-Jensen, C., Giménez-Arnau, A., Bousquet, P. J., Bousquet, J., Canonica, G. W., Church, M. K., Godse, K. V., Grattan, C. E. H., et al. (2011) · Allergy · doi:10.1111/j.1398-9995.2010.02496.x · Cited by 843
Self-citationAllergic Rhinitis and its Impact on Asthma (ARIA): Achievements in 10 years and future needs
Bousquet, J., Schünemann, H. J., Samolinski, B., Demoly, P., Baena-Cagnani, C. E., Bachert, C., Bonini, S., Boulet, L. P., Bousquet, P. J., Brozek, J. L., et al. (2012) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2012.07.053 · Cited by 623
Self-citationSublingual immunotherapy: World Allergy Organization position paper 2013 update
Canonica, G. W., Cox, L., Pawankar, R., Baena-Cagnani, C. E., Blaiss, M., Bonini, S., Bousquet, J., Calderón, M., Compalati, E., Durham, S. R., et al. (2014) · World Allergy Organization Journal · doi:10.1186/1939-4551-7-6 · Cited by 591
Self-citationKlimek, L., Bergmann, K.-C., Biedermann, T., Bousquet, J., Hellings, P., Jung, K., Merk, H., Olze, H., Schlenter, W., Stock, P., et al. (2017) · Allergo Journal International · doi:10.1007/s40629-016-0006-7 · Cited by 475
Self-citationWeller, K., Groffik, A., Church, M. K., Hawro, T., Krause, K., Metz, M., Martus, P., Casale, T. B., Staubach, P., & Maurer, M. (2014) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2013.12.1076 · Cited by 417
Self-citation
Metadata
- Authors
- Baiardini, I., Bousquet, P. J., Brzoza, Z., Canonica, G. W., Compalati, E., Fiocchi, A., Fokkens, W., Van Wijk, R. G., La Grutta, S., Lombardi, C., Maurer, M., Pinto, A. M., Ridolo, E., Senna, G. E., Terreehorst, I., Bom, A. T., Bousquet, J., Zuberbier, T., & Braido, F.
- Venue
- Allergy
- Publisher
- Wiley
- Published
- 2010-02-03
- Volume
- 65
- Issue
- 3
- Pages
- 290-295
- ISSN
- 0105-4538 (ISSN-L)
- 1398-9995
- OpenAlex
- W2001932038
- Cited by
- 107
- References
- 11
- FWCI
- 25.15
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Recommendations for assessing Patient‐Reported Outcomes and Health‐Related quality of life in clinical trials on allergy: a GA2LEN taskforce position paper. https://app.cochat.ai/papers/10.1111/j.1398-9995.2009.02263.x
- The paper
- Baiardini, I., Bousquet, P. J., Brzoza, Z., Canonica, G. W., Compalati, E., Fiocchi, A., Fokkens, W., Van Wijk, R. G., La Grutta, S., Lombardi, C., Maurer, M., Pinto, A. M., Ridolo, E., Senna, G. E., Terreehorst, I., Bom, A. T., Bousquet, J., Zuberbier, T., & Braido, F. (2010). Recommendations for assessing Patient‐Reported Outcomes and Health‐Related quality of life in clinical trials on allergy: a GA2LEN taskforce position paper. Allergy. https://doi.org/10.1111/j.1398-9995.2009.02263.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.